SCHEMBL18053259

SCHEMBL18053259

CC(=O)c1ccc(S(=O)(=O)C2CC(CN(C)C)OC23CCN(C)CC3)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.41
▸ ALDH1A1 P00352 5/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ POLB P06746 2/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NPC1 O15118 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ USP5 P45974 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ CYP19A1 P11511 1/20 0.32
▸ AKR1B1 P15121 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18053260 0.88 ALDH1A1 (0.39) LMNAALDH1A1L3MBTL1KMT2ANPC1
SCHEMBL12623892 0.76 LMNA (0.46) LMNAALDH1A1L3MBTL1POLBKMT2A
SCHEMBL12623903 0.67 ALDH1A1 (0.45) LMNAALDH1A1L3MBTL1POLBKMT2A
SCHEMBL12621853 0.67 ALDH1A1 (0.48) LMNAALDH1A1KMT2ANPC1MAPT
SCHEMBL17553231 0.67 LIMK2 (0.39) LMNAALDH1A1KMT2ANPC1MAPT
SCHEMBL8312504 0.66 LMNA (0.59) LMNAALDH1A1L3MBTL1POLBKMT2A
SCHEMBL12623907 0.65 LMNA (0.43) LMNAALDH1A1POLBKMT2ANPC1
SCHEMBL12626337 0.65 LSS (0.40) LMNAALDH1A1KMT2ANPC1MAPT
SCHEMBL12626325 0.64 LIMK2 (0.44) —
SCHEMBL12623927 0.64 CYP19A1 (0.37) LMNAALDH1A1NPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160251374-A1 FILAMIN A BINDING ANTI-INFLAMMATORY AND ANALGESIC BURNS BARBIER LINDSAY (US) 2016-09-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160251374-A1 FILAMIN A BINDING ANTI-INFLAMMATORY AND ANALGESIC FLNA, FLNB, OPRK1 LMNA 223/4885ALDH1A1 2575/4885L3MBTL1 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback